Immunoregulatory roles of eosinophils: A new look at a familiar cell

Clinical and Experimental Allergy

Volumn 38, Issue 8, 2008, Pages 1254-1263

  Akuthota, P ^b   Wang, H B ^b   Spencer, L A ^b   Weller, P F ^a,b  

^a Dana Bldg   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTIVE IMMUNITY; B LYMPHOCYTE; BASOPHIL; CD4+ T LYMPHOCYTE; DENDRITIC CELL; EOSINOPHIL; HELPER CELL; HUMAN; IMMUNOREGULATION; INNATE IMMUNITY; MAST CELL; NEUTROPHIL; NONHUMAN; POLARIZATION; PRIORITY JOURNAL; RESPIRATORY TRACT ALLERGY; REVIEW; T LYMPHOCYTE;

ANIMALS; EOSINOPHILS; HUMANS; IMMUNITY, INNATE;

EID: 47649120153     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2008.03037.x     Document Type: Review

References (106)

1. Rothenberg ME, Hogan SP. The eosinophil. Annu Rev Immunol 2006 24 : 147 74.
2. Jacobsen EA, Ochkur SI, Lee NA, Lee JJ. Eosinophils and asthma. Curr Allergy Asthma Rep 2007 7 : 18 26.
3. Shi HZ. Eosinophils in asthma. Chin Med J (Engl) 2004 117 : 792 4.
4. Wills-Karp M, Karp CL. Biomedicine. Eosinophils in asthma: remodeling a tangled tale. Science 2004 305 : 1726 9.
5. Adamko D, Lacy P, Moqbel R. Eosinophil function in allergic inflammation: from bone marrow to tissue response. Curr Allergy Asthma Rep 2004 4 : 149 58.
6. Gleich GJ. Mechanisms of eosinophil-associated inflammation. J Allergy Clin Immunol 2000 105 : 651 63.
7. Lacy P, Moqbel R. Eosinophil cytokines. Chem Immunol 2000 76 : 134 55.
8. Lacy P, Moqbel R. Immune effector functions of eosinophils in allergic airway inflammation. Curr Opin Allergy Clin Immunol 2001 1 : 79 84.
9. Moqbel R, Lacy P. New concepts in effector functions of eosinophil cytokines. Clin Exp Allergy 2000 30 : 1667 71.
10. D'Ambrosio D, Mariani M, Panina-Bordignon P, Sinigaglia F. Chemokines and their receptors guiding T lymphocyte recruitment in lung inflammation. Am J Respir Crit Care Med 2001 164 : 1266 75.
11. Lee JJ, Lee NA. Eosinophil degranulation: an evolutionary vestige or a universally destructive effector function? Clin Exp Allergy 2005 35 : 986 94.
12. Adamko DJ, Odemuyiwa SO, Vethanayagam D, Moqbel R. The rise of the phoenix: the expanding role of the eosinophil in health and disease. Allergy 2005 60 : 13 22.
13. Jacobsen EA, Taranova AG, Lee NA, Lee JJ. Eosinophils: singularly destructive effector cells or purveyors of immunoregulation? J Allergy Clin Immunol 2007 119 : 1313 20.
14. Weller PF, Lim K, Wan HC et al. Role of the eosinophil in allergic reactions. Eur Respir J 1996 22 (Suppl) : 109s 15s.
15. Hogan SP, Rosenberg HF, Moqbel R et al. Eosinophils: biological properties and role in health and disease. Clin Exp Allergy 2008 38 : 709 50.
16. Shi HZ. Eosinophils function as antigen-presenting cells. J Leukoc Biol 2004 76 : 520 7.
17. Koeffler HP, Billing R, Levine AM, Golde DW. Ia antigen is a differentiation marker on human eosinophils. Blood 1980 56 : 11 4.
18. Lucey DR, Nicholson-Weller A, Weller PF. Mature human eosinophils have the capacity to express HLA-DR. Proc Natl Acad Sci USA 1989 86 : 1348 51.
19. Hansel TT, Braunstein JB, Walker C et al. Sputum eosinophils from asthmatics express ICAM-1 and HLA-DR. Clin Exp Immunol 1991 86 : 271 7.
20. Beninati W, Derdak S, Dixon PF et al. Pulmonary eosinophils express HLA-DR in chronic eosinophilic pneumonia. J Allergy Clin Immunol 1993 92 : 442 9.
21. Sedgwick JB, Calhoun WJ, Vrtis RF, Bates ME, McAllister PK, Busse WW. Comparison of airway and blood eosinophil function after in vivo antigen challenge. J Immunol 1992 149 : 3710 8.
22. Mawhorter SD, Pearlman E, Kazura JW, Boom WH. Class II major histocompatibility complex molecule expression on murine eosinophils activated in vivo by Brugia malayi. Infect Immun 1993 61 : 5410 2.
23. Yamamoto H, Sedgwick JB, Vrtis RF, Busse WW. The effect of transendothelial migration on eosinophil function. Am J Respir Cell Mol Biol 2000 23 : 379 88.
24. Tamura N, Ishii N, Nakazawa M et al. Requirement of CD80 and CD86 molecules for antigen presentation by eosinophils. Scand J Immunol 1996 44 : 229 38.
25. MacKenzie JR, Mattes J, Dent LA, Foster PS. Eosinophils promote allergic disease of the lung by regulating CD4(+) Th2 lymphocyte function. J Immunol 2001 167 : 3146 55.
26. Shi HZ, Humbles A, Gerard C, Jin Z, Weller PF. Lymph node trafficking and antigen presentation by endobronchial eosinophils. J Clin Invest 2000 105 : 945 53.
27. Celestin J, Rotschke O, Falk K et al. IL-3 induces B7.2 (CD86) expression and costimulatory activity in human eosinophils. J Immunol 2001 167 : 6097 104.
28. Ohkawara Y, Lim KG, Xing Z et al. CD40 expression by human peripheral blood eosinophils. J Clin Invest 1996 97 : 1761 6.
29. Weller PF, Rand TH, Barrett T, Elovic A, Wong DT, Finberg RW. Accessory cell function of human eosinophils. HLA-DR-dependent, MHC-restricted antigen-presentation and IL-1 alpha expression. J Immunol 1993 150 : 2554 62.
30. Hansel TT, De Vries IJ, Carballido JM et al. Induction and function of eosinophil intercellular adhesion molecule-1 and HLA-DR. J Immunol 1992 149 : 2130 6.
31. Mawhorter SD, Kazura JW, Boom WH. Human eosinophils as antigen-presenting cells: relative efficiency for superantigen- and antigen-induced CD4+ T-cell proliferation. Immunology 1994 81 : 584 91.
32. Del Pozo V, De Andres B, Martin E et al. Eosinophil as antigen-presenting cell: activation of T cell clones and T cell hybridoma by eosinophils after antigen processing. Eur J Immunol 1992 22 : 1919 25.
33. Padigel UM, Lee JJ, Nolan TJ, Schad GA, Abraham D. Eosinophils can function as antigen-presenting cells to induce primary and secondary immune responses to Strongyloides stercoralis. Infect Immun 2006 74 : 3232 8.
34. Padigel UM, Hess JA, Lee JJ et al. Eosinophils act as antigen-presenting cells to induce immunity to Strongyloides stercoralis in mice. J Infect Dis 2007 196 : 1844 51.
35. Shi HZ, Xiao CQ, Li CQ et al. Endobronchial eosinophils preferentially stimulate T helper cell type 2 responses. Allergy 2004 59 : 428 35.
36. Duez C, Dakhama A, Tomkinson A et al. Migration and accumulation of eosinophils toward regional lymph nodes after airway allergen challenge. J Allergy Clin Immunol 2004 114 : 820 5.
37. van Rijt LS, Vos N, Hijdra D, de Vries VC, Hoogsteden HC, Lambrecht BN. Airway eosinophils accumulate in the mediastinal lymph nodes but lack antigen-presenting potential for naive T cells. J Immunol 2003 171 : 3372 8.
38. Wang HB, Ghiran I, Matthaei K, Weller PF. Airway eosinophils: allergic inflammation recruited professional antigen-presenting cells. J Immunol 2007 179 : 7585 92.
39. Loss GE Jr., Sant AJ. Invariant chain retains MHC class II molecules in the endocytic pathway. J Immunol 1993 150 : 3187 97.
40. Ziegler HK, Unanue ER. Decrease in macrophage antigen catabolism caused by ammonia and chloroquine is associated with inhibition of antigen presentation to T cells. Proc Natl Acad Sci USA 1982 79 : 175 8.
41. Gounni AS, Lamkhioued B, Ochiai K et al. High-affinity IgE receptor on eosinophils is involved in defence against parasites. Nature 1994 367 : 183 6.
42. Rajakulasingam K, Till S, Ying S et al. Increased expression of high affinity IgE (FcepsilonRI) receptor-alpha chain mRNA and protein-bearing eosinophils in human allergen-induced atopic asthma. Am J Respir Crit Care Med 1998 158 : 233 40.
43. Gounni AS, Lamkhioued B, Masao M et al. Molecular characterization of the low-affinity IgE receptor Fc epsilonRII/CD23 expressed by human eosinophils. Int Immunol 1998 10 : 395 404.
44. Lamkhioued B, Gounni AS, Aldebert D et al. Synthesis of type 1 (IFN gamma) and type 2 (IL-4, IL-5, and IL-10) cytokines by human eosinophils. Ann N Y Acad Sci 1996 796 : 203 8.
45. Woerly G, Roger N, Loiseau S, Capron M. Expression of Th1 and Th2 immunoregulatory cytokines by human eosinophils. Int Arch Allergy Immunol 1999 118 : 95 7.
46. Levi-Schaffer F, Barkans J, Newman TM et al. Identification of interleukin-2 in human peripheral blood eosinophils. Immunology 1996 87 : 155 61.
47. Liu LY, Bates ME, Jarjour NN, Busse WW, Bertics PJ, Kelly EA. Generation of Th1 and Th2 chemokines by human eosinophils: evidence for a critical role of TNF-alpha. J Immunol 2007 179 : 4840 8.
48. Mathew A, MacLean JA, DeHaan E, Tager AM, Green FH, Luster AD. Signal transducer and activator of transcription 6 controls chemokine production and T helper cell type 2 cell trafficking in allergic pulmonary inflammation. J Exp Med 2001 193 : 1087 96.
49. Mikhak Z, Fleming CM, Medoff BD et al. STAT1 in peripheral tissue differentially regulates homing of antigen-specific Th1 and Th2 cells. J Immunol 2006 176 : 4959 67.
50. Liu LY, Mathur SK, Sedgwick JB, Jarjour NN, Busse WW, Kelly EA. Human airway and peripheral blood eosinophils enhance Th1 and Th2 cytokine secretion. Allergy 2006 61 : 589 97.
51. Munitz A, Bachelet I, Eliashar R, Moretta A, Moretta L, Levi-Schaffer F. The inhibitory receptor IRp60 (CD300a) suppresses the effects of IL-5, GM-CSF, and eotaxin on human peripheral blood eosinophils. Blood 2006 107 : 1996 2003.
52. Clutterbuck EJ, Hirst EM, Sanderson CJ. Human interleukin-5 (IL-5) regulates the production of eosinophils in human bone marrow cultures: comparison and interaction with IL-1, IL-3, IL-6, and GMCSF. Blood 1989 73 : 1504 12.
53. Lopez AF, Sanderson CJ, Gamble JR, Campbell HD, Young IG, Vadas MA. Recombinant human interleukin 5 is a selective activator of human eosinophil function. J Exp Med 1988 167 : 219 24.
54. Yamaguchi Y, Hayashi Y, Sugama Y et al. Highly purified murine interleukin 5 (IL-5) stimulates eosinophil function and prolongs in vitro survival. IL-5 as an eosinophil chemotactic factor. J Exp Med 1988 167 : 1737 42.
55. Yamaguchi Y, Suda T, Suda J et al. Purified interleukin 5 supports the terminal differentiation and proliferation of murine eosinophilic precursors. J Exp Med 1988 167 : 43 56.
56. Desreumaux P, Bloget F, Seguy D et al. Interleukin 3, granulocyte-macrophage colony-stimulating factor, and interleukin 5 in eosinophilic gastroenteritis. Gastroenterology 1996 110 : 768 74.
57. Desreumaux P, Janin A, Colombel JF et al. Interleukin 5 messenger RNA expression by eosinophils in the intestinal mucosa of patients with coeliac disease. J Exp Med 1992 175 : 293 6.
58. Desreumaux P, Janin A, Dubucquoi S et al. Synthesis of interleukin-5 by activated eosinophils in patients with eosinophilic heart diseases. Blood 1993 82 : 1553 60.
59. Matthews SP, Tregoning JS, Coyle AJ, Hussell T, Openshaw PJ. Role of CCL11 in eosinophilic lung disease during respiratory syncytial virus infection. J Virol 2005 79 : 2050 7.
60. Sabin EA, Pearce EJ. Early IL-4 production by non-CD4+ cells at the site of antigen deposition predicts the development of a T helper 2 cell response to Schistosoma mansoni eggs. J Immunol 1995 155 : 4844 53.
61. Sabin EA, Kopf MA, Pearce EJ. Schistosoma mansoni egg-induced early IL-4 production is dependent upon IL-5 and eosinophils. J Exp Med 1996 184 : 1871 8.
62. Chen L, Grabowski KA, Xin JP et al. IL-4 induces differentiation and expansion of Th2 cytokine-producing eosinophils. J Immunol 2004 172 : 2059 66.
63. Zhu Y, Chen L, Huang Z et al. Cutting edge: IL-5 primes Th2 cytokine-producing capacity in eosinophils through a STAT5-dependent mechanism. J Immunol 2004 173 : 2918 22.
64. Mohrs M, Shinkai K, Mohrs K, Locksley RM. Analysis of type 2 immunity in vivo with a bicistronic IL-4 reporter. Immunity 2001 15 : 303 11.
65. Shinkai K, Mohrs M, Locksley RM. Helper T cells regulate type-2 innate immunity in vivo. Nature 2002 420 : 825 9.
66. Voehringer D, Shinkai K, Locksley RM. Type 2 immunity reflects orchestrated recruitment of cells committed to IL-4 production. Immunity 2004 20 : 267 77.
67. Gessner A, Mohrs K, Mohrs M. Mast cells, basophils, and eosinophils acquire constitutive IL-4 and IL-13 transcripts during lineage differentiation that are sufficient for rapid cytokine production. J Immunol 2005 174 : 1063 72.
68. Voehringer D, Reese TA, Huang X, Shinkai K, Locksley RM. Type 2 immunity is controlled by IL-4/IL-13 expression in hematopoietic non-eosinophil cells of the innate immune system. J Exp Med 2006 203 : 1435 46.
69. Schmid-Grendelmeier P, Altznauer F, Fischer B et al. Eosinophils express functional IL-13 in eosinophilic inflammatory diseases. J Immunol 2002 169 : 1021 7.
70. Justice JP, Borchers MT, Lee JJ, Rowan WH, Shibata Y, Van Scott MR. Ragweed-induced expression of GATA-3, IL-4, and IL-5 by eosinophils in the lungs of allergic C57BL/6J mice. Am J Physiol Lung Cell Mol Physiol 2002 282 : L302 9.
71. Rumbley CA, Sugaya H, Zekavat SA, El Refaei M, Perrin PJ, Phillips SM. Activated eosinophils are the major source of Th2-associated cytokines in the schistosome granuloma. J Immunol 1999 162 : 1003 9.
72. Bandeira-Melo C, Sugiyama K, Woods LJ, Weller PF. Cutting edge: eotaxin elicits rapid vesicular transport-mediated release of preformed IL-4 from human eosinophils. J Immunol 2001 166 : 4813 7.
73. Bandeira-Melo C, Sugiyama K, Woods LJ et al. IL-16 promotes leukotriene C(4) and IL-4 release from human eosinophils via CD4- and autocrine CCR3-chemokine-mediated signaling. J Immunol 2002 168 : 4756 63.
74. Wang YH, Angkasekwinai P, Lu N et al. IL-25 augments type 2 immune responses by enhancing the expansion and functions of TSLP-DC-activated Th2 memory cells. J Exp Med 2007 204 : 1837 47.
75. Odemuyiwa SO, Ghahary A, Li Y et al. Cutting edge: human eosinophils regulate T cell subset selection through indoleamine 2,3-dioxygenase. J Immunol 2004 173 : 5909 13.
76. Terness P, Bauer TM, Rose L et al. Inhibition of allogeneic T cell proliferation by indoleamine 2,3-dioxygenase-expressing dendritic cells: mediation of suppression by tryptophan metabolites. J Exp Med 2002 196 : 447 57.
77. Jung YJ, Woo SY, Jang MH et al. Human eosinophils show chemotaxis to lymphoid chemokines and exhibit antigen-presenting-cell-like properties upon stimulation with IFN-gamma, IL-3 and GM-CSF. Int Arch Allergy Immunol 2008 146 : 227 34.
78. Holland MJ, Harcus YM, Balic A, Maizels RM. Th2 induction by Nippostrongylus secreted antigens in mice deficient in B cells, eosinophils or MHC Class I-related receptors. Immunol Lett 2005 96 : 93 101.
79. Nakagome K, Dohi M, Okunishi K et al. IL-5-induced hypereosinophilia suppresses the antigen-induced immune response via a TGF-beta-dependent mechanism. J Immunol 2007 179 : 284 94.
80. Jacobsen EA, Ochkur SI, Pero RS et al. Allergic pulmonary inflammation in mice is dependent on eosinophil-induced recruitment of effector T cells. J Exp Med 2008 205 : 699 710.
81. Fulkerson PC, Fischetti CA, McBride ML, Hassman LM, Hogan SP, Rothenberg ME. A central regulatory role for eosinophils and the eotaxin/CCR3 axis in chronic experimental allergic airway inflammation. Proc Natl Acad Sci USA 2006 103 : 16418 23.
82. Grewe M, Czech W, Morita A et al. Human eosinophils produce biologically active IL-12: implications for control of T cell responses. J Immunol 1998 161 : 415 20.
83. Nutku E, Gounni AS, Olivenstein R, Hamid Q. Evidence for expression of eosinophil-associated IL-12 messenger RNA and immunoreactivity in bronchial asthma. J Allergy Clin Immunol 2000 106 : 288 92.
84. Woerly G, Roger N, Loiseau S, Dombrowicz D, Capron A, Capron M. Expression of CD28 and CD86 by human eosinophils and role in the secretion of type 1 cytokines (interleukin 2 and interferon gamma): inhibition by immunoglobulin a complexes. J Exp Med 1999 190 : 487 95.
85. Dajotoy T, Andersson P, Bjartell A, Lofdahl CG, Tapper H, Egesten A. Human eosinophils produce the T cell-attracting chemokines MIG and IP-10 upon stimulation with IFN-gamma. J Leukoc Biol 2004 76 : 685 91.
86. Handzel ZT, Busse WW, Sedgwick JB et al. Eosinophils bind rhinovirus and activate virus-specific T cells. J Immunol 1998 160 : 1279 84.
87. Yang D, Rosenberg HF, Chen Q, Dyer KD, Kurosaka K, Oppenheim JJ. Eosinophil-derived neurotoxin (EDN), an antimicrobial protein with chemotactic activities for dendritic cells. Blood 2003 102 : 3396 403.
88. Yang D, Chen Q, Rosenberg HF et al. Human ribonuclease A superfamily members, eosinophil-derived neurotoxin and pancreatic ribonuclease, induce dendritic cell maturation and activation. J Immunol 2004 173 : 6134 42.
89. Yang D, Chen Q, Su SB et al. Eosinophil-derived neurotoxin acts as an alarmin to activate the TLR2 MyD88 signal pathway in dendritic cells and enhances Th2 immune responses. J Exp Med 2008 205 : 79 90.
90. Lotfi R, Lotze MT. Eosinophils induce DC maturation, regulating immunity. J Leukoc Biol 2008 83 : 456 60.
91. Jordan MB, Mills DM, Kappler J, Marrack P, Cambier JC. Promotion of B cell immune responses via an alum-induced myeloid cell population. Science 2004 304 : 1808 10.
92. Wang HB, Weller PF. Pivotal Advance: Eosinophils mediate early alum adjuvant-elicited B cell priming and IgM production. J Leukoc Biol 2008 83 : 817 21.
93. Munitz A, Levi-Schaffer F. Eosinophils: 'new' roles for 'old' cells. Allergy 2004 59 : 268 75.
94. Munitz A, Piliponsky AM, Levi-Schaffer F. IgE-independent activation of human mast cells indicates their role in the late phase reaction of allergic inflammation. Cell Tissue Bank 2003 4 : 25 8.
95. Piliponsky AM, Gleich GJ, Bar I, Levi-Schaffer F. Effects of eosinophils on mast cells: a new pathway for the perpetuation of allergic inflammation. Mol Immunol 2002 38 : 1369 72.
96. Levi-Schaffer F, Temkin V, Malamud V, Feld S, Zilberman Y. Mast cells enhance eosinophil survival in vitro: role of TNF-alpha and granulocyte- macrophage colony-stimulating factor. J Immunol 1998 160 : 5554 62.
97. Piliponsky AM, Pickholtz D, Gleich GJ, Levi-Schaffer F. Eosinophils activate mast cells to release histamine. Int Arch Allergy Immunol 1999 118 : 202 3.
98. Piliponsky AM, Pickholtz D, Gleich GJ, Levi-Schaffer F. Human eosinophils induce histamine release from antigen-activated rat peritoneal mast cells: a possible role for mast cells in late-phase allergic reactions. J Allergy Clin Immunol 2001 107 : 993 1000.
99. O'Donnell MC, Ackerman SJ, Gleich GJ, Thomas LL. Activation of basophil and mast cell histamine release by eosinophil granule major basic protein. J Exp Med 1983 157 : 1981 91.
100. Piliponsky AM, Gleich GJ, Nagler A, Bar I, Levi-Schaffer F. Non-IgE-dependent activation of human lung- and cord blood-derived mast cells is induced by eosinophil major basic protein and modulated by the membrane form of stem cell factor. Blood 2003 101 : 1898 904.
101. Hartman M, Piliponsky AM, Temkin V, Levi-Schaffer F. Human peripheral blood eosinophils express stem cell factor. Blood 2001 97 : 1086 91.
102. Horigome K, Bullock ED, Johnson EM Jr. Effects of nerve growth factor on rat peritoneal mast cells. Survival promotion and immediate-early gene induction. J Biol Chem 1994 269 : 2695 702.
103. Solomon A, Aloe L, Pe'er J et al. Nerve growth factor is preformed in and activates human peripheral blood eosinophils. J Allergy Clin Immunol 1998 102 : 454 60.
104. Moy JN, Gleich GJ, Thomas LL. Noncytotoxic activation of neutrophils by eosinophil granule major basic protein. Effect on superoxide anion generation and lysosomal enzyme release. J Immunol 1990 145 : 2626 32.
105. Shenoy NG, Gleich GJ, Thomas LL. Eosinophil major basic protein stimulates neutrophil superoxide production by a class IA phosphoinositide 3-kinase and protein kinase C-zeta-dependent pathway. J Immunol 2003 171 : 3734 41.
106. Page SM, Gleich GJ, Roebuck KA, Thomas LL. Stimulation of neutrophil interleukin-8 production by eosinophil granule major basic protein. Am J Respir Cell Mol Biol 1999 21 : 230 7.